Annual Current Liabilities
$145.34 M
+$104.81 M+258.64%
December 31, 2023
Summary
- As of February 26, 2025, PCVX annual total current liabilities is $145.34 million, with the most recent change of +$104.81 million (+258.64%) on December 31, 2023.
- During the last 3 years, PCVX annual current liabilities has risen by +$98.48 million (+210.15%).
- PCVX annual current liabilities is now at all-time high.
Performance
PCVX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$123.79 M
+$40.94 M+49.42%
September 30, 2024
Summary
- As of February 26, 2025, PCVX quarterly total current liabilities is $123.79 million, with the most recent change of +$40.94 million (+49.42%) on September 30, 2024.
- Over the past year, PCVX quarterly current liabilities has stayed the same.
- PCVX quarterly current liabilities is now -14.83% below its all-time high of $145.34 million, reached on December 31, 2023.
Performance
PCVX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PCVX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +258.6% | 0.0% |
| 3 y3 years | +210.2% | +160.8% |
| 5 y5 years | +2065.0% | - |
PCVX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +406.1% | -14.8% | +354.3% |
| 5 y | 5-year | at high | +1215.0% | -14.8% | +1020.1% |
| alltime | all time | at high | +2065.0% | -14.8% | +1020.1% |
Vaxcyte Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $123.79 M(+49.4%) |
| Jun 2024 | - | $82.85 M(-4.9%) |
| Mar 2024 | - | $87.10 M(-40.1%) |
| Dec 2023 | $145.34 M(+258.6%) | $145.34 M(+69.9%) |
| Sep 2023 | - | $85.56 M(+42.1%) |
| Jun 2023 | - | $60.22 M(+14.2%) |
| Mar 2023 | - | $52.75 M(+30.2%) |
| Dec 2022 | $40.52 M | $40.52 M(+3.1%) |
| Sep 2022 | - | $39.31 M(+29.0%) |
| Jun 2022 | - | $30.47 M(+11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $27.25 M(-5.1%) |
| Dec 2021 | $28.72 M(-38.7%) | $28.72 M(-39.5%) |
| Sep 2021 | - | $47.46 M(+16.6%) |
| Jun 2021 | - | $40.70 M(-26.0%) |
| Mar 2021 | - | $55.02 M(+17.4%) |
| Dec 2020 | $46.86 M(+324.0%) | $46.86 M(+18.3%) |
| Sep 2020 | - | $39.61 M(+20.4%) |
| Jun 2020 | - | $32.89 M(+34.1%) |
| Mar 2020 | - | $24.52 M(+121.9%) |
| Dec 2019 | $11.05 M(+64.6%) | $11.05 M |
| Dec 2018 | $6.71 M | - |
FAQ
- What is Vaxcyte annual total current liabilities?
- What is the all time high annual current liabilities for Vaxcyte?
- What is Vaxcyte annual current liabilities year-on-year change?
- What is Vaxcyte quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Vaxcyte?
- What is Vaxcyte quarterly current liabilities year-on-year change?
What is Vaxcyte annual total current liabilities?
The current annual current liabilities of PCVX is $145.34 M
What is the all time high annual current liabilities for Vaxcyte?
Vaxcyte all-time high annual total current liabilities is $145.34 M
What is Vaxcyte annual current liabilities year-on-year change?
Over the past year, PCVX annual total current liabilities has changed by +$104.81 M (+258.64%)
What is Vaxcyte quarterly total current liabilities?
The current quarterly current liabilities of PCVX is $123.79 M
What is the all time high quarterly current liabilities for Vaxcyte?
Vaxcyte all-time high quarterly total current liabilities is $145.34 M
What is Vaxcyte quarterly current liabilities year-on-year change?
Over the past year, PCVX quarterly total current liabilities has changed by $0.00 (0.00%)